AVCN — Avicanna Inc.

Price Chart

12 months daily · TSX:AVCN

Insider Transactions

90-day window · 16 filings

Date	Insider	Role	Nature	Dir.	Shares	Buy Price	Return	Value
Jun 18, 2026	Michael Kott	—	Other	Buy	90,909	$0.13	-3.8% · 21d	$12K
Jun 18, 2026	Azadian, Aras	—	Exercise	Buy	628,418	$0.13	-3.8% · 21d	$82K
Jun 18, 2026	Azadian, Aras	—	Exercise	Sell	628,418	$0.13	—	$82K
Jun 18, 2026	Azadian, Aras	—	Comp. Grant	Buy	75,000	—	—	—
Jun 18, 2026	Azadian, Aras	—	Comp. Grant	Buy	1,000,000	—	—	—
Jun 18, 2026	Hilborn, Nicholas	—	Exercise	Buy	86,394	$0.13	-3.8% · 21d	$11K
Jun 18, 2026	Michael Kott	—	Open Market	Buy	225,500	$0.13	-3.8% · 21d	$29K
Jun 17, 2026	Michael Kott	—	Open Market	Buy	54,500	$0.13	-3.8% · 22d	$7K
Jun 16, 2026	Michael Kott	—	Open Market	Buy	109,000	$0.13	-4.1% · 23d	$14K
Jun 15, 2026	Michael Kott	—	Open Market	Buy	211,000	$0.13	-5.9% · 24d	$28K
Jun 12, 2026	Kilic, Ozgur	—	Open Market	Sell	230,000	$0.15	—	$34K
Jun 12, 2026	Kilic, Ozgur	—	Open Market	Sell	115,000	$0.20	—	$23K
Jun 12, 2026	Michael Kott	—	Open Market	Sell	333,000	$0.15	—	$50K
Jun 12, 2026	Michael Kott	—	Open Market	Sell	166,500	—	—	—
Jun 10, 2026	Azadian, Aras	—	Comp. Grant	Buy	225,000	$0.13	-3.8% · 29d	$29K
Jun 10, 2026	Azadian, Aras	—	Comp. Grant	Buy	403,418	$0.13	-3.8% · 29d	$52K

Score uses open-market buys only · 4 open-market · 7 plan / compensation shown but not scored · Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.

Score Breakdown

Signal Analyst · $29/mo

Component	Points	Max	Detail
Conviction (unique buyers) ✓ FREE PREVIEW	30	30	1 unique buyer (maximum conviction)
Buy/sell ratio		20	44% buys (4B / 5S)
Dollar value		25	$79K
Lobbying activity		15	None
Contract wins		10	None
Insider track record		10	No track record data
Private placements		8	None
Confluence bonus		10	None
Cluster timing (velocity)		10	No coordinated buying cluster detected
Buy/sell reversal pattern		8	No buy/sell reversal pattern
Total	0	100

Unlock Component Detail — CAD $29/mo

Buying Insiders

Open-market · 90 days · 1 unique buyer

Insider	Credibility	Hit Rate	Avg 90d Return	Trades (eval'd)	Buy Value (90d)	Last Buy
Michael Kott	—	—	—	—	$79K	Jun 18, 2026

Credibility score: historical hit rate × avg 90d return × sample size. View full insider leaderboard →

Lobbying Registrations

OCL active · none found

No active OCL lobbying registrations in the last 90 days. Analyst plan →

Government Contract Wins

90-day window · none found

No government contract wins in the last 90 days. Analyst plan →

Private Placements

12 months · Signal Analyst · $29/mo

Private placement history, deal size, and lock-up expiry tracking. Analyst plan →

Indigenous Consultation

no records on file

No Indigenous consultation records on file for AVCN.

SEDAR+ Filings

official filing registry

Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →

Short Interest

CIRO · Jun 30, 2026

Shares short

80,963

Net change

-18,318 (-18.5%)

History

Jun 30: 80,963

Jun 15: 99,281

May 31: 122,338

May 15: 84,893

Apr 30: 39,277

Apr 15: 41,321

Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).

Clinical Trials

ClinicalTrials.gov · 2 trials

Phase	Status	Trial	Updated
NA	Completed	Effect of a Facial Cream Containing Cannabidiol and Hemp Oil on Skin H	Apr 2020
NA	Completed	Effect of an Emollient Cream Containing 0.5% Cannabidiol and 1% Hemp O	Apr 2020

Trials where this company is the lead sponsor (ClinicalTrials.gov). Phase advances, completions and terminations are material catalysts for clinical-stage companies — not investment advice.